AFT Forsyth & Company Inc. Sells 120 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

AFT Forsyth & Company Inc. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 9,209 shares of the medical equipment provider’s stock after selling 120 shares during the period. Intuitive Surgical comprises approximately 2.4% of AFT Forsyth & Company Inc.’s holdings, making the stock its 9th largest holding. AFT Forsyth & Company Inc.’s holdings in Intuitive Surgical were worth $4,807,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the 3rd quarter worth $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $589.61 on Thursday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market cap of $210.01 billion, a price-to-earnings ratio of 91.98, a P/E/G ratio of 5.67 and a beta of 1.39. The firm has a 50-day moving average of $556.91 and a 200-day moving average of $516.98.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Mizuho increased their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 over the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.